ForMED Ventures

ForMED Ventures, founded in 2015 and based in New Taipei City, Taiwan, is a venture capital firm that specializes in early-stage investments within the healthcare and medical technology sectors. The firm primarily targets opportunities in life sciences, medical devices, digital health, and biotechnology. With a mission to enhance healthcare by addressing unmet medical needs and improving quality of life, ForMED Ventures focuses its investments mainly in Israel, the United States, and Europe. By supporting innovative companies, the firm aims to contribute to advancements in healthcare solutions.

Michael Blomeyer

General Partner

3 past transactions

Aqua Medical

Series A in 2020
Aqua Medical, Inc. is a medical technology company that specializes in developing vapor-based, endoscopic ablation systems aimed at treating gastrointestinal diseases and preventing gastrointestinal cancers. Founded in 2016 by Virender K. Sharma, the company is headquartered in Santa Ana, California. Its innovative ablation technology utilizes high-temperature water vapor generated by a radiofrequency generator, which is delivered endoscopically through proprietary catheters to various parts of the gastrointestinal tract. This platform enables medical practitioners to perform effective, non-surgical treatments for conditions such as pancreatic cysts and esophageal issues, offering a convenient and efficient alternative to traditional surgical methods.

Eximis Surgical

Series A in 2020
Eximis Surgical develops a laparoscopic specimen removal device that uses RF energized cutting wires within a containment bag to enable rapid extraction of large specimens through small incisions. Founded in 2014 and based in Louisville, Colorado, the company aims to integrate its device into standard surgical protocols to shorten procedure times, reduce patient discomfort, and maintain safety. The system segments specimens into narrow strips to produce clean tissue blocks for pathology, supporting minimally invasive surgery and enabling surgeons to perform complex resections with less invasiveness.

Advanced NanoTherapies

Seed Round in 2019
Advanced NanoTherapies, Inc. is a biotechnology company focused on developing innovative medical devices utilizing Sirolimus and biodegradable functionalized nanoparticle technology for the treatment of atherosclerosis and related conditions, including coronary artery disease and peripheral artery disease. Founded in 2018, the company is headquartered in Cleveland, Ohio. Advanced NanoTherapies aims to enhance drug delivery through its proprietary platform, which improves medication uptake and retention at the cellular level. This technology provides clinicians with safer treatment options for patients suffering from cardiovascular and endovascular diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.